CN Patent

CN106455567A — 用于治疗青光眼的组合物和方法

Assigned to GNT LLC · Expires 2017-02-22 · 9y expired

What this patent protects

本发明提供了α‑2肾上腺素能受体激动剂组合物和用于治疗青光眼及其他眼内病情的方法。在本发明的组合物和方法中优选使用的α‑2激动剂是右旋美托咪啶。

USPTO Abstract

本发明提供了α‑2肾上腺素能受体激动剂组合物和用于治疗青光眼及其他眼内病情的方法。在本发明的组合物和方法中优选使用的α‑2激动剂是右旋美托咪啶。

Drugs covered by this patent

chembl-chembl2106195 (DEXMEDETOMIDINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN106455567A
Jurisdiction: CN
Classification: —
Expires: 2017-02-22
Drug substance claim: No
Drug product claim: No
Assignee: GNT LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.